Informing on health and wellness news in Djibouti

Provided by AGP

Djibouti Health Journal
Got News to Share?
Got News to Share? Explore more publications!

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 20, 2026

ONWARD Medical Publishes Closing of Bookbuild Offering
Apr. 20, 2026

ONWARD Medical Publishes Closing of Bookbuild Offering

Indeterminate GlobeNewswire
Naomi Ruth Cohen Institute For Mental Health Education to Host Annual Conference Addressing the Growing Crisis of Loneliness
Apr. 20, 2026

Naomi Ruth Cohen Institute For Mental Health Education to Host Annual Conference Addressing the Growing Crisis of Loneliness

Indeterminate GlobeNewswire
Global Vascular Access Device Market to Reach USD 8.68 Billion by 2031 | MarketsandMarkets™
Apr. 20, 2026

Global Vascular Access Device Market to Reach USD 8.68 Billion by 2031 | MarketsandMarkets™

Indeterminate GlobeNewswire
AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses
Apr. 20, 2026

AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses

Indeterminate GlobeNewswire
Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations
Apr. 20, 2026

Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations

Indeterminate GlobeNewswire
ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform
Apr. 20, 2026

ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform

Indeterminate GlobeNewswire
BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform
Apr. 20, 2026

BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform

Indeterminate GlobeNewswire
Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
Apr. 20, 2026

Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

Indeterminate GlobeNewswire
HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc.
Apr. 20, 2026

HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc.

Indeterminate GlobeNewswire
AVIS À IGNORER -- BVI Medical, Inc.
Apr. 20, 2026

AVIS À IGNORER -- BVI Medical, Inc.

Indeterminate GlobeNewswire
$3.2+ BN Medical Radiation Shielding Market Forecasts to 2034: Rising More Imaging and Therapy Procedures Due to Growing Chronic Diseases and Increasing Risk Awareness
Apr. 20, 2026

$3.2+ BN Medical Radiation Shielding Market Forecasts to 2034: Rising More Imaging and Therapy Procedures Due to Growing Chronic Diseases and Increasing Risk Awareness

Indeterminate GlobeNewswire
Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc.
Apr. 20, 2026

Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc.

Indeterminate GlobeNewswire
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
Apr. 20, 2026

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

Indeterminate GlobeNewswire
First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases
Apr. 20, 2026

First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases

Indeterminate GlobeNewswire
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
Apr. 20, 2026

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

Indeterminate GlobeNewswire
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
Apr. 20, 2026

Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA

Indeterminate GlobeNewswire
Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa
Apr. 20, 2026

Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa

Indeterminate GlobeNewswire
Rpharmy Completes SOC 2® Type II Audit, Reinforcing Its Commitment to Data Security in Healthcare
Apr. 20, 2026

Rpharmy Completes SOC 2® Type II Audit, Reinforcing Its Commitment to Data Security in Healthcare

Indeterminate GlobeNewswire
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
Apr. 20, 2026

Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond

Indeterminate GlobeNewswire
Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026
Apr. 20, 2026

Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn

Sign up for:

Djibouti Health Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.